This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.
SLU PP 332
Experimental Research Peptide
/WHAT_IT_IS
SLU-PP-332 is an experimental peptide under early-stage investigation for its effects on metabolic regulation and potential nootropic effects.
/USAGE
Studied for potential impacts on mitochondrial function, endurance capacity, and cognitive processes in preclinical models.
/MECHANISM_OF_ACTION
Believed to influence metabolic signaling, possibly via modulation of PGC-1α and mitochondrial biogenesis pathways.
Reported Benefits
- +Enhanced energy regulation
- +May support mitochondrial health
- +Potential cognitive benefits
Reported Side Effects
- −Not well-documented
- −Unknown long-term effects
/STACKED_WITH
/RESEARCH_NOTES
Only recommended for experienced labs; long-term human safety data not available.
/REFERENCE
https://pubmed.ncbi.nlm.nih.gov/37739806//RELATED
Browse all 89 in the app.
MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.